Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis.
To evaluate the feasibility and safety of stent implantation to treat ostial vertebral artery stenosis. Fifty-eight symptomatic patients (44 men; mean age 72 years, range 54 to 88) with 67 ostial vertebral artery lesions received 67 balloon-expandable coronary stents. Follow-up angiography was performed if restenosis was suspected or during later catheterization for other indications. Restenosis was defined as >50% diameter narrowing. Technical success was 100%. Periprocedural neurological complications included 2 (3.4%) posterior and 1 (1.7%) anterior strokes. Other complications included 1 (1.7%) massive gastrointestinal hemorrhage requiring blood transfusion and endoscopic therapy, 1 (1.7%) femoral pseudoaneurysm requiring surgical repair, and 1 (1.7%) large shoulder hematoma secondary to a ruptured small branch of the thoracoacromial artery. Antiplatelet medication was discontinued in the ulcer patient, and the vertebral stent occluded at 8 months. At a mean follow-up of 31.3+/-17.1 months, 1 (1.7%) patient died after coronary bypass 2 months after stenting. One (1.7%) patient reported recurrent dizziness at 14 months and had angiographic evidence of in-stent restenosis. Angiographic evaluation of 32 (48%) lesions at a mean 11.0+/-9.6 months uncovered restenosis in 8 (25%) vessels, including the 2 cases noted above. Aside from these 2 patients, none of the other patients with restenosis were symptomatic. Multivariant Cox regression analysis showed reference vessel diameter as the only independent predictor of restenosis. Symptomatic ostial vertebral artery stenosis can be treated with relative safety using coronary techniques and equipment. Reference vessel diameter was the only predictor of restenosis in vertebral artery ostial stents.